• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Radiofrequency Microdebridement as an Adjunct to Arthroscopic Surgical Treatment for Recalcitrant Gluteal Tendinopathy: A Double-Blind, Randomized Controlled Trial
【24h】

Radiofrequency Microdebridement as an Adjunct to Arthroscopic Surgical Treatment for Recalcitrant Gluteal Tendinopathy: A Double-Blind, Randomized Controlled Trial

机译：射频微小杂种作为顽固性衰弱肌腱病的关节镜手术治疗的辅助微生物：双盲，随机对照试验

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: Recalcitrant greater trochanteric pain is increasingly recognized as an indication for surgical intervention. The arthroscopic approach has become rapidly more common than the open alternative. Hypothesis: Patients undergoing radiofrequency microdebridement (RFMD) as an adjunct to arthroscopic gluteal bursectomy (AGB) and iliotibial band release (ITBR) will experience better functional improvement than AGB and ITBR alone at 1 year. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: A total of 33 patients with failed nonoperative treatment of gluteal tendinopathy were randomly allocated to undergo AGB/ITBR or AGB/ITBR + RFMD. Full-thickness tears were excluded. The primary outcome measure was the modified Harris Hip Score (mHHS) at 52 weeks. Secondary outcome measures included the mHHS, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), visual analog scale (VAS) for pain, and 12-item Short Form Health Survey (SF-12), which were evaluated at 0, 6, 12, 24, and 52 weeks. Statistical significance was defined as P & .05. Results: A total of 33 participants (33 hips; 30 female and 3 male; mean age, 58 years) were randomized; 16 patients underwent AGB/ITBR + RFMD, and 17 underwent AGB/ITBR. Participants’ functionality improved in both groups at all time intervals. The mean mHHS score improved from 57.49 ± 10.61 to 77.76 ± 18.40 ( P = .004) and from 58.98 ± 12.33 to 79.96 ± 18.86 ( P = .001) at 52 weeks in the AGB/ITBR and AGB/ITBR + RFMD groups, respectively, although there was no statistically significant difference between groups. There were no device-related adverse events. Conclusion: AGB/ITBR led to significant improvements in patients with recalcitrant gluteal tendinopathy. In this small RCT, the addition of RFMD showed no additional benefit to AGB/ITBR but provided a safe adjunct for the surgical management of recalcitrant gluteal tendinopathy. Registration: NCT01562366 ( ClinicalTrials.gov identifier).
机译：背景：荷兰普林普族更大的Trochanteric疼痛越来越被认为是手术干预的指示。关节镜方法变得迅速比开放的替代品更常见。假设：接受射频微量杂交（RFMD）作为关节镜衰弱术（AGB）和ITBRIBIAL BAND释放（ITBR）的患者将在1年内仅经历更好的功能改善，而不是AGB和ITBR。研究设计：随机对照试验;证据水平，2.方法：随机分配了33例衰弱治疗衰弱的衰弱治疗患者，经过AGB / ITBR或AGB / ITBR + RFMD。全厚的泪液被排除在外。主要结果措施是52周的修饰哈里斯髋关节评分（MHHS）。次要结果措施包括MHHS，西部的安大略省和麦克马斯特大学骨关节炎指数（WOWAC），疼痛的视觉模拟量表（VAS），以及12件短型健康调查（SF-12），评估为0,6,12 ，24和52周。统计显着性被定义为p＆ .05。结果：共有33名参与者（33髋; 30名女性和3只男性;平均年龄，58岁）被随机分配; 16名患者接受了AGB / ITBR + RFMD，17名AGB / ITBR。参与者的功能在所有时间间隔内都在两个群体中得到改善。在AGB / ITBR和AGB / ITBR + RFMD组52周，平均MHHS评分从57.49±10.61到77.76±18.40（p = .004）和58.98±12.33％（p = .001）。分别是虽然组之间没有统计学上显着差异。没有设备相关的不良事件。结论：AGB / ITBR导致顽固性衰老肌腱病患者的显着改善。在这个小的RCT中，AGB / ITBR的添加额外的额外效益，但为顽皮胫骨病患者的手术管理提供了安全的辅助。注册：NCT01562366（ClinicalTrials.gov标识符）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号